Evidence map›Paper›PMID 24296975›Full record

ArticleMolecular psychiatry2014

Nicotine consumption is regulated by a human polymorphism in dopamine neurons.

C Morel, L Fattore, S Pons, Y A Hay, F Marti, B Lambolez, M De Biasi, M Lathrop, W Fratta, U Maskos and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Pooled it
  2. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Pooled it
  3. Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  4. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. "Unraveling the role ofReceptors (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

C MorelNeurobiologie des Processus Adaptatifs, CNRS UMR 7102, Equipe Neurophysiologie et comportement (NPC), Université P. et M. Curie, Paris, France.
L FattoreCNR Neuroscience Institute, Cagliari, National Research Council, Italy, Cittadella Universitaria, Monserrato, Italy.
S PonsInstitut Pasteur, Unité Neurobiologie intégrative des systèmes cholinergiques, CNRS UMR 3571, Paris, France.
Y A HayUniversité P. et M. Curie, CNRS UMR 7102, Neurobiologie des Processus Adaptatifs, Equipe Réseau cortical et couplage neurovasculaire, Paris, France.
F MartiNeurobiologie des Processus Adaptatifs, CNRS UMR 7102, Equipe Neurophysiologie et comportement (NPC), Université P. et M. Curie, Paris, France.
B LambolezUniversité P. et M. Curie, CNRS UMR 7102, Neurobiologie des Processus Adaptatifs, Equipe Réseau cortical et couplage neurovasculaire, Paris, France.
M De BiasiDepartment of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
M Lathrop1] McGill University and Genome Quebec Innovation Centre, Montréal, QC, Canada [2] Fondation Jean Dausset, CEPH, Paris, France.
W FrattaDepartment of Biomedical Sciences, University of Cagliari Cittadella Universitaria, Monserrato, Italy.
U MaskosInstitut Pasteur, Unité Neurobiologie intégrative des systèmes cholinergiques, CNRS UMR 3571, Paris, France.
P FaureNeurobiologie des Processus Adaptatifs, CNRS UMR 7102, Equipe Neurophysiologie et comportement (NPC), Université P. et M. Curie, Paris, France.
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRMcGill University and Génome Québec Innovation Centre · CANeuroscience Institute · ITUniversity of Cagliari · ITUniversity of Pennsylvania · US

Funding

Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Genetic Influences Over Nicotine WithdrawalR21DA029157 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI DE BIASI, MARIELLA · 2010 to 2011
$420k
NCI NIH HHS U19 CA148127NCI NIH HHS U19CA148127NIDA NIH HHS DA029157NIDA NIH HHS R21 DA029157
6 · The paper itself

Abstract

Smoking is the most important preventable cause of morbidity and mortality worldwide. Recent genome-wide association studies highlighted a human haplotype on chromosome 15 underlying the risk for tobacco dependence and lung cancer. Several polymorphisms in the CHRNA3-CHRNA5-CHRNB4 cluster coding for the nicotinic acetylcholine receptor (nAChR) α3, α5 and β4 subunits were implicated. In mouse models, we define a key role in the control of sensitivity to nicotine for the α5 subunit in dopaminergic (DAergic) neurons of the ventral tegmental area (VTA). We first investigated the reinforcing effects of nicotine in drug-naive α5(-/-) mice using an acute intravenous nicotine self-administration task and ex vivo and in vivo electrophysiological recordings of nicotine-elicited DA cell activation. We designed lentiviral re-expression vectors to achieve targeted re-expression of wild-type or mutant α5 in the VTA, in general, or in DA neurons exclusively. Our results establish a crucial role for α5*-nAChRs in DAergic neurons. These receptors are key regulators that determine the minimum nicotine dose necessary for DA cell activation and thus nicotine reinforcement. Finally, we demonstrate that a single-nucleotide polymorphism, the non-synonymous α5 variant rs16969968, frequent in many human populations, exhibits a partial loss of function of the protein in vivo. This leads to increased nicotine consumption in the self-administration paradigm. We thus define a critical link between a human predisposition marker, its expression in DA neurons and nicotine intake.

Indexed as

Action PotentialsAnimalsDopaminergic NeuronsMaleMiceMice, KnockoutNicotinePolymorphism, Single NucleotideReceptors, NicotinicReinforcement, PsychologySelf AdministrationVentral Tegmental AreaCHRNA5 protein, mouseNicotineReceptors, Nicotinic

Identifiers

PMID24296975
PMCPMC8596967
OpenAlexW2010762896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.